Disentangling minimum clinically important difference for an individual and a population in the treatment of Alzheimer's disease
Abstract Recent accelerated and traditional approval of anti‐amyloid therapies by the U.S. Food and Drug Administration for the treatment of patients with early Alzheimer's disease has stimulated heated debate on whether or not the benefits of these therapeutic agents achieve a minimum clinical...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.70093 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|